Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by mercedesmanon Sep 15, 2023 7:04pm
186 Views
Post# 35639251

RE:RE:Greatest feeling ever

RE:RE:Greatest feeling ever

The statement would seem to support the notion that FDA approval (of PMX in the Tigris " confirmatory" Trial, is about as close to 100% as you can probably get !!!

Too bad American investors don't yet know that Spectral would then have an exclusive lock on a Target market of between $2B and $5B USD annually. 

And Baxter, their multi-billion $ distributor, already has 50% market penetration on the pumps needed to use the filters almost everywhere. 


MM 

<< Previous
Bullboard Posts
Next >>